Risk biomarker assessment for breast cancer progression: Replication precision of nuclear morphometry

被引:13
作者
Poulin, N
Frost, A
Carraro, A
Mommers, E
Guillaud, M
van Diest, PJ
Grizzle, W
Beenken, S
机构
[1] BC Canc Res Ctr, Vancouver, BC, Canada
[2] Free Univ Amsterdam, Inst Pathol, NL-1081 HV Amsterdam, Netherlands
[3] Univ Alabama, Dept Surg, Birmingham, AL 35294 USA
[4] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA
来源
ANALYTICAL CELLULAR PATHOLOGY | 2003年 / 25卷 / 03期
关键词
image analysis; image cytometry; reproducibility; standardization;
D O I
10.1155/2003/262918
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nuclear morphometry is a method for quantitative measurement of histopathologic changes in the appearance of stained cell nuclei. Numerous studies have indicated that these assessments may provide clinically relevant information related to the degree of progression and malignant potential of breast neoplasia. Nuclear features are derived from computerized analysis of digitized microscope images, and a quantitative Feulgen stain for DNA was used. Features analyzed included: (1) DNA content; (2) nuclear size and shape; and (3) texture features, describing spatial features of chromatin distribution. In this study replicated measurements are described on a series of 54 breast carcinoma specimens of differing pathologic grades. Duplicate measurements were performed using two serial sections, which were processed and analyzed separately. The value of a single feature measurement, the nuclear area profile, was shown to be the strongest indicator of progression. A quantitative nuclear grade was derived and shown to be strongly correlated with not only the pathologic nuclear grade, but also with tubule formation, mitotic grade, and with the overall histopathologic grade. Analysis of replication precision showed that the standard methods of the histopathology laboratory, if practiced in a uniform manner, are sufficient to ensure reproducibility of these assessments. We argue that nuclear morphometry provides a standardized and reproducible framework for quantitative pathologic assessments.
引用
收藏
页码:129 / 138
页数:10
相关论文
共 20 条
[1]   DISEASE-FREE SURVIVAL OF NODE-POSITIVE BREAST-CANCER PATIENTS - IMPROVED PROGNOSTICATION BY CYTOMETRIC PARAMETERS [J].
AUBELE, M ;
AUER, G ;
VOSS, A ;
FALKMER, U ;
RUTQUIST, L ;
HOFLER, H .
PATHOLOGY RESEARCH AND PRACTICE, 1995, 191 (10) :982-990
[2]   Prognostic and predictive factors in breast cancer [J].
Bundred, NJ .
CANCER TREATMENT REVIEWS, 2001, 27 (03) :137-142
[3]  
DALTON LW, 1994, CANCER, V73, P2765, DOI 10.1002/1097-0142(19940601)73:11<2765::AID-CNCR2820731119>3.0.CO
[4]  
2-K
[5]  
DAVIS BW, 1986, CANCER-AM CANCER SOC, V58, P2662, DOI 10.1002/1097-0142(19861215)58:12<2662::AID-CNCR2820581219>3.0.CO
[6]  
2-Y
[7]  
DELIDES GS, 1982, ARCH PATHOL LAB MED, V106, P126
[8]  
Doudkine A., 1995, Pathologica (Genoa), V87, P286
[9]   PATHOLOGICAL PROGNOSTIC FACTORS IN BREAST-CANCER .1. THE VALUE OF HISTOLOGICAL GRADE IN BREAST-CANCER - EXPERIENCE FROM A LARGE STUDY WITH LONG-TERM FOLLOW-UP [J].
ELSTON, CW ;
ELLIS, IO .
HISTOPATHOLOGY, 1991, 19 (05) :403-410
[10]   Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model [J].
Fabian, CJ ;
Kimler, BF ;
Zalles, CM ;
Klemp, JR ;
Kamel, S ;
Zeiger, S ;
Mayo, MS .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (15) :1217-1227